Rudat V, Bachmann N, Küpper J H, Weber K J
Abteilung Klinische Radiologie, Universitätsklinikum Heidelberg, Germany.
Int J Radiat Biol. 2001 Mar;77(3):303-7. doi: 10.1080/09553000010009026.
To assess the influence of trans-dominant inhibition of poly(ADP-ribosyl)ation on the rejoining kinetics of radiation-induced DNA double-strand breaks (DSB).
Stable transfectants of the SV40-transformed hamster cell line CO60 were used: COM3 cells contain a construct to overexpress the poly(ADP-ribose) polymerase (PARP-1) DNA-binding domain (DBD) when induced by dexamethasone, as well as a construct for the constitutive overexpression of the human glucocorticoid receptor (Hg0). COR3 are control cells containing only the Hg0 plasmid. DSB induction and rejoining in X-irradiated cells was assessed by DNA pulsed-field electrophoresis.
DSB induction was identical in both cell lines and independent of the presence of dexamethasone. DSB rejoining kinetics was independent of dexamethasone in COR3 cells and identical to COM3 cells without dexamethasone. However, in COM3 cells treated with dexamethasone to induce PARP-1 DBD overexpression, the fast component of the rejoining kinetic was largely reduced, and residual fragmentation increased concomitant with the increased damage fraction in slow rejoining.
The results indicate that inhibition of cellular PARP-1 does not affect the rate-limiting step of either fast or slow DSB rejoining. Rather, it appears that absence of poly(ADP-ribosyl)ation due to dominant negative PARP-1 expression induces a shift from rapid to slow DSB rejoining and by this mechanism PARP inhibition may increase the risk of repair failures.
评估多聚(ADP - 核糖)化的反式显性抑制对辐射诱导的DNA双链断裂(DSB)重接动力学的影响。
使用SV40转化的仓鼠细胞系CO60的稳定转染子:COM3细胞包含一个构建体,当用地塞米松诱导时可过表达多聚(ADP - 核糖)聚合酶(PARP - 1)的DNA结合结构域(DBD),以及一个用于组成型过表达人糖皮质激素受体(Hg0)的构建体。COR3是仅包含Hg0质粒的对照细胞。通过DNA脉冲场电泳评估X射线照射细胞中的DSB诱导和重接情况。
两种细胞系中的DSB诱导情况相同,且与地塞米松的存在无关。COR3细胞中的DSB重接动力学与地塞米松无关,且与未用地塞米松处理的COM3细胞相同。然而,在用糖皮质激素处理以诱导PARP - 1 DBD过表达的COM3细胞中,重接动力学的快速成分大幅降低,残余片段化增加,同时慢重接中的损伤分数增加。
结果表明,抑制细胞PARP - 1不会影响快速或慢速DSB重接的限速步骤。相反,由于显性负性PARP - 1表达导致的多聚(ADP - 核糖)化缺失似乎会诱导从快速DSB重接向慢速DSB重接的转变,通过这种机制,PARP抑制可能会增加修复失败的风险。